Enhancement of human papillomavirus (HPV) type 16 E6 and E7-specific T-cell immunity in healthy volunteers through vaccination with TA-CIN, an HPV16 L2E6E7 fusion protein vaccine. - de Jong,A.; O’Neil,T.; Khan,A.Y.; Kwappenberg,K.M.; Chrisholm,S.E.; Whittle,N.R.; Dobson,J.A.; Jack,L.C.; St Clair Roberts,J.A.; Offringa,R.; van der Burg,S.H.; Hickling,J.K. (Vaccine, 2002)